By Drug Class / Mechanism

SNP Array Genotyping Market Analysis

Cross-industry research covering SNP Array Genotyping across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering SNP Array Genotyping

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

SNP arrays remain the workhorse of ancestry and wellness kits due to low per-sample cost (sub-USD 30 at scale), but face structural displacement as WGS prices compress. The technology is mature and its share is in secular decline through the forecast period.

38%

Market Share

2.9%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments